Cellestia

Our People

Cellestia is led by a senior management team with a proven track record in cancer biology discovery and research, drug development, business development and regulatory affairs.

The Team

Dr. Michael Bauer

Chief Executive Officer
Board Member

More info

Dr. Rajwinder Lehal

Chief Scientific Officer
Board Member

More info

Dr. Maximilien Murone

Chief Operating Officer

More info

Gaudenz von Capeller

Chief Financial Officer

More info

Mathilde Claire Vincent

Head of Communication

More info

Dr. Pavel Pisa

Medical Director

More info

Dr. Laura Beni

Head of Clinical Operations

More info

Board of Directors

Dr. Guido Guidi

Chairman of the Board

More info

Dr. Michael Bauer

Chief Executive Officer
Board Member

More info

Dr. Rajwinder Lehal

Chief Scientific Officer
Board Member

More info

Prof. Radek Spisek

Board Member

More info

Melissa K. Epstein

Board Member

More info

Robert Karsunky

Board member

More info

Advisory boards

David R. Epstein

Chairman of the Strategic Advisory Boards

More info

Prof. Douglas Hanahan

Director of the Swiss Institute for Experimental Cancer Research
EPFL

More info

Prof. Jon Aster

Prof. of Pathology and Chief of the Division of Hematopathology
Brigham and Women's Hospital and Harvard Medical School

More info

Prof. Chantal Csajka

Associate Professor at the School of Pharmaceutical Sciences
University of Geneva and Lausanne & University Hospital in Lausanne

More info

Dr. Robert A. Ettlin

Chief Executive Officer
Ettlin Consulting AG

More info

Dr. Doriano Fabbro

Chief Scientific Officer
Piqur Therapeutics

More info

Prof. Rhett Kovall

Assoc. Prof. University of Cincinnati College of Medicine
Dept. of Molecular Genetics, Biochemistry and Microbiology

More info

Dr. Marc Lang

Scientific Advisor

More info

Dr. Josep Tabernero

Professor of Oncology, Head of the Medical Oncology Department
Vall d' Hebron University Hospital in Barcelona
Director of the Vall d' Hebron Institute of Oncology

More info

Dr. Javier Cortés

IOB Institute of Oncology, Quironsalud Group, Madrid & Barcelona
Vall d'Hebron Institute of Oncology

More info

Prof. Richard Herrmann

Professor of Oncology
University of Basel

More info

Dr. Paolo Nuciforo

Head Molecular Oncology Group
Vall d'Hebron Institute of Oncology

More info

Prof. Francesc Bosch Albareda

Prof. of Hematology & Head of the Dept. of Hematology
University Hospital Vall d’Hebron, Barcelona

More info

Dr. Anton Hagenbeek

Professor of Hematology
Academic Medical Center, University of Amsterdam,
the Netherlands

More info

Dr. Christophe Massard

Chair of Drug Development Department (DITEP),
Gustave Roussy, Villejuif, France

More info

Dr. Renata Ferrarotto

Assoc. Prof. & Director of the Head and Neck Clinical Research Program
MD Anderson Cancer Center, Houston

More info

Dr. Carlos L. Arteaga

The Lisa K. Simmons Distinguished Chair in Comprehensive Oncology
Director, UT Southwestern Harold C. Simmons Cancer Center
Professor of Medicine and Associate Dean of Oncology Programs
UT Southwestern Medical Center

More info

Roger Meier

Chief Executive Officer
Clarena AG

More info

Ralf Rosenow

Managing Partner
OSICOS AG

More info